BEONE MEDICINES' 'Baiyue Da' Achieves First Sales Transaction in Beijing
Product Launch: CHINA NATIONAL MEDICINE has been appointed as the preferred distributor for BEONE MEDICINES' new product, Baiyue Da, in Beijing.
Successful Delivery: The first order delivery of Baiyue Da was completed efficiently, with the medication arriving at Sinopharm Logistics and reaching the designated pharmacy within three hours.
Collaboration: The successful delivery was made possible through the cooperation of CHINA NATIONAL MEDICINE's procurement center, Beijing direct sales center, and Sinopharm Logistics.
Market Activity: BEONE MEDICINES is experiencing short selling activity, with a reported short selling amount of $134.34 million and a ratio of 12.328%.
Get Free Real-Time Notifications for Any Stock
Analyst Views on 06160
About the author
CICC Identifies Possible 'Blue Chip' Stocks for HSI Semi-Annual Adjustment Predictions (Table)
CICC Report on HSI Adjustments: CICC predicts potential blue chip stocks for inclusion in the HSI based on semi-annual adjustments and quantitative criteria, highlighting companies like ZIJIN GOLD INTL and YUM CHINA.
Short Selling and Inflows: The report details short selling ratios and inflows for various stocks, indicating market activity and investor sentiment towards companies such as BEONE MEDICINES and XPENG-W.
Potential Replacements for HANG SENG BANK: Following the delisting of HANG SENG BANK, companies like STANCHART and SWIREPROPERTIES are identified as potential candidates to fill the vacancy.
Market Performance Overview: The report includes a snapshot of stock performance, with some companies experiencing gains while others face declines, reflecting the mixed market conditions.
CICC Forecasts Inclusion of ZIJIN GOLD INTL, BEONE MEDICINES, PICC P&C, and AKESO in HSI; STANCHART Likely to Take HANG SENG BANK's Place
Annual Review Announcement: The Hang Seng Indexes Company will announce the results of its annual review of major Hong Kong stock indices on February 13, which will impact the eligible stocks for Southbound Stock Connect.
Potential New Additions: CICC forecasts that ZIJIN GOLD INTL, YUM CHINA, and BEONE MEDICINES are likely to meet the inclusion criteria for the Hang Seng Index, while several other companies may fill the gap left by HANG SENG BANK's removal.
Market Capitalization Considerations: Companies like STANCHART, SWIREPROPERTIES, and SINO LAND are also potential candidates for inclusion based on market capitalization and industry coverage, though their inclusion remains uncertain.
Southbound Stock Connect Adjustments: CICC anticipates that 44 stocks, including JD INDUSTRIALS and CHUANGXIN IND, will become eligible for inclusion in Southbound Stock Connect, while 25 stocks may be removed from the list.
